share_log

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, ANVS and ATIP

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, ANVS and ATIP

克萊因律師事務所提醒投資者注意代表CCIV、ANVS和ATIP的股東提起集體訴訟
Accesswire ·  2021/08/28 23:45

NEW YORK, NY / ACCESSWIRE / August 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

紐約州紐約/ACCESSWIRE /2021 年 8 月 29 日/ 克萊因律師事務所宣佈,已代表以下公司的股東提起集體訴訟。參加該套裝不收取任何費用。 如果你蒙受了損失,你必須在首席原告的最後期限之前要求法院任命你爲首席原告。

Churchill Capital Corp IV (NYSE:CCIV) 
Class Period: January 11, 2021 - February 22, 2021
Lead Plaintiff Deadline: August 30, 2021

丘吉爾資本第四公司(紐約證券交易所代碼:CCIV) 
上課時間: 2021年1月11日-2021年2月22日
首席原告截止日期: 2021年8月30日

The complaint alleges that throughout the class period Churchill Capital Corp IV made materially false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

投訴稱,在整個集體訴訟期間,丘吉爾資本公司四世作出了重大虛假和/或誤導性陳述和/或未能披露:(1)Lucid 沒有準備在 2021 年春季交付汽車;(2) Lucid 預計在 2021 年將生產 557 輛汽車,而不是與丘吉爾合併前吹捧的 6,000 輛汽車;(3) 鑑於上述情況,被告對公司的正面陳述業務、運營和潛在客戶存在重大誤導和/或缺乏合理依據。當真實細節進入市場時,訴訟聲稱投資者遭受了損失。

Learn about your recoverable losses in CCIV : http://www.kleinstocklaw.com/pslra-1/churchill-capital-corp-iv-loss-submission-form?id=19082&from=1

在 CCIV 中瞭解您的可追回損失 : http://www.kleinstocklaw.com/pslra-1/churchill-capital-corp-iv-loss-submission-form?id=19082&from=1

Annovis Bio, Inc. (NYSE American:ANVS) 
Class Period: May 21, 2021 - July 28, 2021
Lead Plaintiff Deadline: October 18, 2021

Annovis Bio, Inc.(紐約證券交易所美國股票代碼:ANVS) 
上課時間: 2021年5月21日-2021年7月28日
首席原告截止日期: 2021年10月18日

The ANVS lawsuit alleges that Annovis Bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

ANVS訴訟稱,Annovis Bio, Inc.作出了重大虛假和/或誤導性陳述和/或未能披露:(1)Annovis的 ANVS401(Posiphen)是一種口服藥物,據稱可抑制作爲神經變性主要原因的神經毒性蛋白的合成,但在方向、判斷和問題解決等因素方面,沒有在兩個患者羣體中顯示出具有統計學意義的結果;以及(2)綜上所述,被告對公司業務、運營的正面陳述以及潛在客戶存在重大誤導和/或缺乏合理的依據。

Learn about your recoverable losses in ANVS : https://www.kleinstocklaw.com/pslra-1/annovis-bio-inc-loss-submission-form?id=19082&from=1

瞭解您在 ANVS 中可收回的損失 : https://www.kleinstocklaw.com/pslra-1/annovis-bio-inc-loss-submission-form?id=19082&from=1

ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II (NYSE:ATIP) 
This lawsuit is on behalf of investors who: (a) purchased or otherwise acquired ATI securities between April 1, 2021 and July 23, 2021, inclusive and/or (b) held FVAC Class A common stock as of May 24, 2021 and were eligible to vote at FVAC's June 15, 2021 special meeting.
Lead Plaintiff Deadline: October 15, 2021

ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Cor 
本訴訟代表以下投資者:(a)在2021年4月1日至2021年7月23日期間(包括在內)購買或以其他方式收購了ATI證券和/或(b)截至2021年5月24日持有FVAC A類普通股並有資格在FVAC的2021年6月15日特別會議上投票。
首席原告截止日期: 2021年10月15日

The complaint alleges that throughout the class period ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II made materially false and/or misleading statements and/or failed to disclose that: (1) ATI was experiencing attrition among its physical therapists; (2) ATI faced increasing competition for clinicians in the labor market; (3) as a result of the foregoing, the Company faced difficulties retaining therapists and incurred increased labor costs; (4) as a result of the labor shortage, the Company would open fewer new clinics; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

該投訴稱,在整個集體訴訟期間,ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II 作出了重大虛假和/或誤導性陳述和/或未能披露:(1) ATI 在勞動力市場面臨日益激烈的臨床醫生競爭;(3) 由於上述原因,公司在留住治療師方面面臨困難,勞動力成本增加;(4) 由於由於勞動力短缺,公司將減少開設的新診所;(5) 因此在上述情況中,被告對公司業務、運營和前景的正面陳述具有重大誤導性和/或缺乏合理的依據。

Learn about your recoverable losses in ATIP : https://www.kleinstocklaw.com/pslra-1/ati-physical-therapy-inc-f-k-a-fortress-value-acquisition-corp-ii-loss-submission-form?id=19082&from=1

在 ATIP 中瞭解您的可收回損失 : https://www.kleinstocklaw.com/pslra-1/ati-physical-therapy-inc-f-k-a-fortress-value-acquisition-corp-ii-loss-submission-form?id=19082&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

您無需擔任首席原告即可參與任何賠償。如果您在上課期間蒙受損失並希望獲得更多信息,請致電 212-616-4899 與 J. Klein, Esq. 聯繫,或訪問提供的網頁。

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

J. Klein,Esq. 代表投資者並參與全國範圍內涉及金融欺詐的證券訴訟。律師廣告。先前的結果並不能保證類似的結果。

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com 
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

聯繫人:
J. Klein,Esq
帝國大廈
第五大道 350 號
第 59 層
紐約州紐約 10118
jk@kleinstocklaw.com
電話:(212) 616-4899
傳真:(347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

來源: 克萊因律師事務所


View source version on accesswire.com:
在 accesswire.com 上查看源代碼版本:

https://www.accesswire.com/661847/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-CCIV-ANVS-and-ATIP
https://www.accesswire.com/661847/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-CCIV-ANVS-and-ATIP

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論